Sana Biotechnology files to go public, looks to cure disease by modifying genes in the body
GeekWire
JANUARY 13, 2021
Less than three years after it was founded and with no revenue on the books, Sana Biotechnology has f iled to go public. While Sana says its approach is applicable to a number of diseases, some of its most advance research is being done around cancer. And like many biotechnology companies it is losing money. stake in Sana.
Let's personalize your content